Pharma Medica
Armando DeSousa has a strong work experience spanning over 20 years. Armando started their career as a Senior Associate at Howie & Partners Chartered Accountants in 1995. After three years, they moved on to PwC, where they worked as an Audit Manager until 2000. At Valeo, Armando held two key roles - Plant Controller from 2004-2005 and R&D Financial Controller from 2000-2004. Since 2005, they have been serving as the Vice President & Chief Financial Officer at Pharma Medica Research Inc.
Armando DeSousa completed their education in accounting and finance, focusing on professional certifications and a bachelor's degree. In 1992, they enrolled at the University of Windsor and graduated in 1997 with a Bachelor of Commerce (B.Comm.) degree. Following this, in 1997, they pursued further professional development by attending the Canadian Institute of Chartered Accountants, obtaining a CA qualification. Armando then sought to expand their expertise and enrolled at the American Institute of Certified Public Accountants in 1998 to achieve the Certified Public Accountant (CPA) designation in Illinois. Armando DeSousa's educational journey showcases their commitment to acquiring relevant qualifications in the field of accounting. Additionally, Armando obtained a certification called "Leading with Vision" from LinkedIn in December 2020, demonstrating their continuous pursuit of professional growth and development.
Pharma Medica
Pharma Medica Research Inc is a full service contract research organization based in the greater Toronto area. We focus primarily on phase I, first-in-man, and bioequivalence trials in healthy volunteers, special populations, and patients. By remaining specialized in this area, we have developed true expertise in the field. Our track record speaks for itself we have completed over 1500 clinical trials, been successfully audited by the FDA and EMEA, and helped to bring over 250 drugs to markets. Through an uncompromising commitment to quality and service, a reputation for on-time performance, innovation at all levels, and delivery of services at reasonable costs, we have become trusted partners of many of the worlds leading pharmaceutical companies.